In particular, our results showed that the increase in serotonin levels induced by SSRIs activates 5-HT1A receptors, and enhances hippocampal neurogenesis and dendritic spine remodeling, thus regulating anxiety and depression behaviors by affecting the nNOS-CAPON interaction. The gene discussed is HTR1A; the disease is depressive symptom measurement.